About LCT Blog

Welcome to LCT Blog, LCT Magazine's blog devoted to "stretching chauffeured transportation." The LCT team appreciates you clicking in, and hopes you'll find some useful and entertaining information. Read more

Contributors

Martin Romjue

Martin Romjue joined LCT Magazine as editor on Jan. 2, 2008. He most recently worked as a business editor for the Los Angeles Newspaper Group, and previously reported at newspapers in Virginia, Florida, and California. Read more

Jim Luff

Jim Luff is an operator from Bakersfield, CA who wears a few different hats. Jim began his career in the industry as a private chauffeur in 1990. In 1993 he found a permanent home at The Limousine Scene as the general manager, later becoming a partner. Read more

Michael Campos

Michael Campos joined LCT Magazine as assistant editor on January 3, 2011. He is a graduate of the University of Southern California’s English/Creative Writing program. Michael attended his first International LCT Show in February 2011, where he met and interacted with operators and vendors. He will be helping LCT further develop its digital media content. Read more

Keep Your Eye On The Prize: Pharmaceutical Companies

DON’T LET THEM KILL DRUG COMPANY TRAVEL: Let’s face it. The U.S. pays the highest prices in the world for drugs. When eyes move away from the AIGs of the world and their “travel abuses,” the next casualty may very well be doctors. How dare they accept a trip from a pharmaceutical company to go to a beautiful resort and learn about the advantages of a new drug while ending the day with a round of golf? The public will be in an uproar. Physicians will stop traveling for fear of losing their practices when their educational trips are unveiled to the public. 
 
So you think it won’t happen? Look at the domino effect AIG caused to the travel industry. Companies that never took government monies stopped incentive travel for fear of the negative perception these trips may have had. Wait until the media unveils the billions of dollars that drug manufacturers spend convincing physicians that their product is the next best thing. Gone are the days when physicians have a cache of pens all emblazoned with Viagra. The tissue boxes branded with Alegra and mint jars that sit on the sign-in counter will be a thing of the past. But these amount to pennies compared to the spending on educational trips. 
 
I have worked many pharm groups in my career, and although there are some elements of a junket in these trips, I believe that the true benefits far outweigh the junket aspects. Consider this: Physicians from around the world who specialize in treating patients with AIDS attend meetings hosted by drug manufacturers to learn of their newest drugs.
 
This gives those physicians yet another opportunity to meet with their colleagues from different parts of the world in a more casual environment to share ideas and observations. When a group of smart people get together, it is amazing what results can occur. But in the eyes of the politicians, it is all about dollars and cents. 
 
As transportation providers for these businesses, we need to watch closely the direction health care reform is going. Elimination of spending on this type of travel can and may be slipped into a bill unnoticed. At the 11th hour in some back room, our industry could be dealt yet another devastating blow. I encourage all of us to read everything that is published on health care reform and watch closely for any comments on incentives and travel.
 
— Linda Moore, East Coast Editor 
Print | posted on Tuesday, June 23, 2009 10:10 AM
blog comments powered by Disqus Please add 4 and 1 and type the answer here: